Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

RBC Capital Sticks to Their Buy Rating for Healthpeak Properties (DOC)

Tipranks - Tipranks - Tue Dec 23, 2025

RBC Capital analyst Michael Carroll maintained a Buy rating on Healthpeak Properties on December 19 and set a price target of $21.00. The company’s shares closed last Friday at $15.99.

Claim 70% Off TipRanks This Holiday Season

According to TipRanks, Carroll is a 4-star analyst with an average return of 7.2% and a 60.40% success rate. Carroll covers the Real Estate sector, focusing on stocks such as Americold Realty, Alexandria Equities, and Healthpeak Properties.

Currently, the analyst consensus on Healthpeak Properties is a Moderate Buy with an average price target of $19.73, which is a 23.39% upside from current levels. In a report released on December 15, Evercore ISI also reiterated a Buy rating on the stock with a $21.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on Healthpeak Properties’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $705.87 million and a GAAP net loss of $117.12 million. In comparison, last year the company earned a revenue of $700.4 million and had a net profit of $85.87 million

Read More on DOC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).